- Report
- September 2025
- 634 Pages
Global
From €6412EUR$7,150USD£5,547GBP
- Report
- October 2025
- 120 Pages
Global
From €5336EUR$5,950USD£4,616GBP
- Report
- March 2026
- 338 Pages
Global
From €2242EUR$2,500USD£1,940GBP
- Report
- March 2026
- 453 Pages
Global
From €5246EUR$5,850USD£4,539GBP
- Report
- January 2026
- 195 Pages
Global
From €3179EUR$3,545USD£2,750GBP
€3533EUR$3,939USD£3,056GBP
- Report
- January 2026
- 187 Pages
Global
From €3179EUR$3,545USD£2,750GBP
€3533EUR$3,939USD£3,056GBP
- Report
- August 2025
- 196 Pages
Global
From €3179EUR$3,545USD£2,750GBP
€3533EUR$3,939USD£3,056GBP
- Report
- June 2025
- 185 Pages
Global
From €4036EUR$4,500USD£3,491GBP
- Report
- February 2026
- 250 Pages
Global
From €4027EUR$4,490USD£3,483GBP
- Report
- March 2026
- 541 Pages
Global
From €5246EUR$5,850USD£4,539GBP
- Report
- March 2026
- 174 Pages
Global
From €5246EUR$5,850USD£4,539GBP
- Report
- March 2025
- 371 Pages
Global
From €3991EUR$4,450USD£3,452GBP
- Report
- January 2026
- 160 Pages
Global
From €3012EUR$3,358USD£2,605GBP
€3542EUR$3,950USD£3,064GBP
- Report
- January 2026
- 160 Pages
Global
From €3012EUR$3,358USD£2,605GBP
€3542EUR$3,950USD£3,064GBP
- Report
- September 2025
- 321 Pages
Global
From €1972EUR$2,199USD£1,706GBP
- Report
- July 2025
- 235 Pages
Global
From €4304EUR$4,799USD£3,723GBP
- Report
- November 2025
- 120 Pages
Global
From €5336EUR$5,950USD£4,616GBP
- Report
- January 2026
- 189 Pages
Global
From €3179EUR$3,545USD£2,750GBP
€3533EUR$3,939USD£3,056GBP
- Report
- August 2025
- 199 Pages
Global
From €3179EUR$3,545USD£2,750GBP
€3533EUR$3,939USD£3,056GBP
- Report
- August 2025
- 182 Pages
Global
From €3179EUR$3,545USD£2,750GBP
€3533EUR$3,939USD£3,056GBP

The Contract Research Organization (CRO) market within the biotechnology sector is a rapidly growing industry. It provides services to biotechnology companies, such as drug discovery, preclinical and clinical trials, and regulatory affairs. CROs are often used to outsource research and development activities, allowing biotechnology companies to focus on their core competencies. CROs also provide access to specialized expertise and resources, such as specialized laboratory equipment and personnel.
CROs are increasingly being used to reduce costs and speed up the development process. They are also used to reduce the risk associated with drug development, as they can provide access to a wide range of expertise and resources.
Some of the major companies in the CRO market include Parexel, Quintiles, Charles River Laboratories, Covance, and PRA Health Sciences. Show Less Read more